Preview

Федеральные клинические рекомендации по диагностике и лечению болезни Грейвса у детей

https://doi.org/10.14341/probl201460359-68

Полный текст:

Аннотация

Болезнь Грейвса в детском возрасте встречается достаточно редко, чаще болеют девочки. Для широкого обсуждения предлагается проект клинических рекомендаций по диагностике и лечению болезни Грейвса у детей и подростков. Рекомендации предназначены для детских эндокринологов, педиатров, хирургов, специалистов по радиоизотопному лечению.

Об авторе

О Б Безлепкина
ФГБУ «Эндокринологический научный центр» Минздрава России, Москва
Россия


Список литературы

1. Дедов И.И., Петеркова В.А. Детская эндокринология. Руководство для врачей. – М.: УП-Принт; 2006. 595с. [Dedov II, Peterkova VA. Pediatric endocrinology. Guidance for doctors. Moscow: UP-Print; 2006. 595p.]

2. Эндокринология. Национальное руководство. / Под редакцией акад. РАН и РАМН И.И.Дедова, чл.-кор. РАМН Г.А.Мельниченко. / Подготовлено под эгидой Российской ассоциации эндокринологов и Ассоциации медицинских обществ по качеству. — М: ГЭОТАР-Медиа, 2011.

3. [Endocrinology. National Guidelines. Ed by I.I.Dedov, G.A.Melnichenko. Moscow: GEOTAR-Media; 2011.]

4. Ajjan RA, Weetman AP. Techniques to quantify TSH receptor antibodies. Nature Clinical Practice Endocrinology & Metabolism. 2008;4(8):461-8. doi: 10.1038/ncpendmet0886

5. Bahn RS, Burch HB, Cooper DS, Garber JR, Greenlee MC, Klein I, et al. Hyperthyroidism and Other Causes of Thyrotoxicosis: Management Guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid. 2011;21(6):593-646. doi: 10.1089/thy.2010.0417

6. Bergman P, Auldist AW, Cameron F. Review of the outcome of management of Graves' disease in children and adolescents. J Paediatr Child Health. 2001;37(2):176-82. doi: 10.1046/j.1440-1754.2001.00641.x

7. Brown RS. Autoimmune thyroid disease: unlocking a complex puzzle. Curr Opin Pediatr. 2009;21(4):523-8. doi: 10.1097/MOP.0b013e32832cf824

8. Brown RS. Disorders of the Thyroid Gland in Infants, Children, and Adolescents. In DeGroot LJ. Thyroid Disease Manager. South Dartmouth: Endocrine Education, Inc.; 2012. Available on: http://www.thyroidmanager.org/chapter/disorders-of-the-thyroid-gland-in-infancy-childhood-and-adolescence/

9. Cappelli C, Gandossi E, Castellano M, Pizzocaro C, Agosti B, Delbarba A, et al. Prognostic Value of Thyrotropin Receptor Antibodies (TRAb) in Graves' Disease: A 120 Months Prospective Study. Endocr J. 2007;54(5):713-20. doi: 10.1507/endocrj.K06-069

10. Cooper DS, Rivkees SA. Putting Propylthiouracil in Perspective. The Journal of Clinical Endocrinology & Metabolism. 2009;94(6):1881-2. doi: 10.1210/jc.2009-0850

11. Glaser NS, Styne DM. Predicting the Likelihood of Remission in Children With Graves' Disease: A Prospective, Multicenter Study. Pediatrics. 2008;121(3):e481-e8. doi: 10.1542/peds.2007-1535

12. Hamburger JI. Management of Hyperthyroidism in Children and Adolescents. The Journal of Clinical Endocrinology & Metabolism. 1985;60(5):1019-24. doi: 10.1210/jcem-60-5-1019

13. Hermsen D, Eckstein A, Schinner S, Willenberg H, Thiel A, Scherbaum W, et al. Reproducibility of Elecsys®Anti-TSHR Test Results in a Lot-to-Lot Comparison. Horm Metab Res. 2010;42(04):295-7. doi: 10.1055/s-0029-1246188

14. Kaguelidou F, Alberti C, Castanet M, Guitteny M-A, Czernichow P, Léger J. Predictors of Autoimmune Hyperthyroidism Relapse in Children after Discontinuation of Antithyroid Drug Treatment. The Journal of Clinical Endocrinology & Metabolism. 2008;93(10):3817-26. doi: 10.1210/jc.2008-0842

15. Kaguelidou F, Carel JC, eacute, ger J. Graves’ Disease in Childhood: Advances in Management with Antithyroid Drug Therapy. Horm Res. 2009;71(6):310-7. doi: 10.1159/000223414

16. Lippe BM, Landaw EM, Kaplan SA. Hyperthyroidism in Children Treated with Long Term Medical Therapy: Twenty-Five Percent Remission Every Two Years*. The Journal of Clinical Endocrinology & Metabolism. 1987;64(6):1241-5. doi: 10.1210/jcem-64-6-1241

17. Lytton SD, Kahaly GJ. Bioassays for TSH-receptor autoantibodies: An update. Autoimmunity Reviews. 2010;10(2):116-22. doi: 10.1016/j.autrev.2010.08.018

18. Pedersen IB, Handberg A, Knudsen N, Heickendorff L, Laurberg P. Assays for Thyroid-Stimulating Hormone Receptor Antibodies Employing Different Ligands and Ligand Partners May Have Similar Sensitivity and Specificity but Are Not Interchangeable. Thyroid. 2010;20(2):127-33. doi: 10.1089/thy.2009.0105

19. Rahhal SN, Eugster EA. Thyroid Stimulating Immunoglobulin is Often Negative in Children with Graves' Disease. J Pediatr Endocrinol Metab. 2008;21(11). doi: 10.1515/jpem.2008.21.11.1085

20. Raza J, Hindmarsh PC, Brook CGD. Thyrotoxicosis in children: thirty years’experience. Acta Paediatr. 2007;88(9):937-41. doi: 10.1111/j.1651-2227.1999.tb00185.x

21. Rivkees SA, Cornelius EA. Influence of Iodine-131 Dose on the Outcome of Hyperthyroidism in Children. Pediatrics. 2003;111(4):745-9. doi: 10.1542/peds.111.4.745

22. Rivkees SA, Dinauer C. An Optimal Treatment for Pediatric Graves’ Disease Is Radioiodine. The Journal of Clinical Endocrinology & Metabolism. 2007;92(3):797-800. doi: 10.1210/jc.2006-1239

23. Rivkees SA, Sklar C, Freemark M. The Management of Graves’ Disease in Children, with Special Emphasis on Radioiodine Treatment. The Journal of Clinical Endocrinology & Metabolism. 1998;83(11):3767-76. doi: 10.1210/jcem.83.11.5239

24. Rivkees S, Stephenson K, Dinauer C. Adverse Events Associated with Methimazole Therapy of Graves' Disease in Children. Int J Pediatr Endocrinol. 2010;2010(1):176970. doi: 10.1186/1687-9856-2010-176970

25. Rivkees SA, Szarfman A. Dissimilar Hepatotoxicity Profiles of Propylthiouracil and Methimazole in Children. The Journal of Clinical Endocrinology & Metabolism. 2010;95(7):3260-7. doi: 10.1210/jc.2009-2546

26. Ron E, Lubin JH, Shore RE, Mabuchi K, Modan B, Pottern LM, et al. Thyroid Cancer after Exposure to External Radiation: A Pooled Analysis of Seven Studies. Radiat Res. 1995;141(3):259. doi: 10.2307/3579003

27. Segni M, Leonardi E, Mazzoncini B, Pucarelli IDA, Pasquino AM. Special Features of Graves' Disease in Early Childhood. Thyroid. 1999;9(9):871-7. doi: 10.1089/thy.1999.9.871

28. Sherman J, Thompson GB, Lteif A, Schwenk WF, van Heerden J, Farley DR, et al. Surgical management of Graves disease in childhood and adolescence: an institutional experience. Surgery. 2006;140(6):1056-62. doi: 10.1016/j.surg.2006.07.040

29. Shulman DI, Muhar IVY, Jorgensen EV, Diamond FB, Bercu BB, Root AW. Autoimmune Hyperthyroidism in Prepubertal Children and Adolescents: Comparison of Clinical and Biochemical Features at Diagnosis and Responses to Medical Therapy. Thyroid. 1997;7(5):755-60. doi: 10.1089/thy.1997.7.755

30. Smith J, Brown RS. Persistence of Thyrotropin (TSH) Receptor Antibodies in Children and Adolescents with Graves' Disease Treated Using Antithyroid Medication. Thyroid. 2007;17(11):1103-7. doi: 10.1089/thy.2007.0072

31. Smith BR, Sanders J, Furmaniak J. TSH Receptor Antibodies. Thyroid. 2007;17(10):923-38. doi: 10.1089/thy.2007.0239

32. Zöphel K, Roggenbuck D, Wunderlich G, Schott M. Continuously Increasing Sensitivity over Three Generations of TSH Receptor Autoantibody Assays. Horm Metab Res. 2010;42(12):900-2. doi: 10.1055/s-0030-1267171


Для цитирования:


Безлепкина О.Б. Федеральные клинические рекомендации по диагностике и лечению болезни Грейвса у детей. Проблемы Эндокринологии. 2014;60(3):59-68. https://doi.org/10.14341/probl201460359-68

For citation:


Bezlepkina O.B. Federal clinical recommendations on diagnostics and treatment of Graves' disease in the children. Problems of Endocrinology. 2014;60(3):59-68. (In Russ.) https://doi.org/10.14341/probl201460359-68

Просмотров: 37


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 0375-9660 (Print)
ISSN 2308-1430 (Online)